Today's guest post comes from Divya Iyer, SVP, Head of Revenue, Pharma Direct at GoodRx. Divya examines why direct-to-consumer strategies shouldn't default to mail-order as the endpoint for every program. She argues that preserving patient choice between retail pickup and home delivery can reduce friction, improve therapy initiation, and strengthen the overall patient experience. To learn more about GoodRx's Pharma Direct solution, visit GoodRx Pharma Direct. Read on for Divya's insights. Read more » © 2006-2026 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved. This Feed is for personal non-commercial use only.
Today's guest post comes from Divya Iyer, SVP, Head of Revenue, Pharma Direct at GoodRx.
Divya examines why direct-to-consumer strategies shouldn't default to mail-order as the endpoint for every program. She argues that preserving patient choice between retail pickup and home delivery can reduce friction, improve therapy initiation, and strengthen the overall patient experience.
To learn more about GoodRx's Pharma Direct solution,
visit GoodRx Pharma Direct.
Read on for Divya's insights.
Read more »
US Pharma Marketing
